CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 4 Open-market buy Chief Operating Officer bought 42 shares at an average $7.88 ($331)
- 4 Grant or award Trachtenberg Eric acquired 61,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 61,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 81,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 178,300 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 61,000 shares (grant or award)
- 4 Grant or award Trachtenberg Eric acquired 16,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 16,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Exercise or conversion Director acquired 4,824 shares (option exercise)
- 4 Grant or award Chief Executive Officer acquired 49,560 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Other acquisition Director acquired 2,361 shares (other)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 19,000 shares (grant or award)
- 4 Grant or award Director acquired 28,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 16,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 19,000 shares (grant or award)
Page 9 of 15 · 288 filings